Search results for "Pharmacological"

showing 10 items of 131 documents

Stilbenes and resveratrol metabolites improve mitochondrial fatty acid oxidation defects in human fibroblasts

2014

International audience; Background: Inborn enzyme defects of mitochondrial fatty acid beta-oxidation (FAO) form a large group of genetic disorders associated to variable clinical presentations ranging from life-threatening pediatric manifestations up to milder late onset phenotypes, including myopathy. Very few candidate drugs have been identified in this group of disorders. Resveratrol (RSV) is a natural polyphenol with anti-oxidant and anti-inflammatory effects, recently shown to have beneficial metabolic properties in mice models. Our study explores its possible effects on FAO and mitochondrial energy metabolism in human cells, which are still very little documented.Methods: Using cells …

[SDV]Life Sciences [q-bio]Blotting WesternStimulationMitochondrionResveratrolBiologyPharmacology03 medical and health scienceschemistry.chemical_compound0302 clinical medicineIn vivoStilbenesmedicineHumansGenetics(clinical)Pharmacology (medical)CarnitinePatient fibroblastsGenetics (clinical)030304 developmental biologyPiceidEC50Medicine(all)chemistry.chemical_classification0303 health sciencesResearchFatty Acidsfood and beveragesMitochondrial FAO defectsPharmacological therapyGeneral MedicineFibroblastsMitochondria3. Good health[SDV] Life Sciences [q-bio]EnzymechemistryResveratrolOxidation-Reduction030217 neurology & neurosurgerymedicine.drug
researchProduct

Differential memory persistence of odor mixture and components in newborn rabbits: competition between the whole and its parts

2014

Interacting with the mother during the daily nursing, newborn rabbits experience her body odour cues. In particular, the mammary pheromone (MP) contained in rabbit milk triggers the typical behaviour which helps to localize and seize the nipples. It also promotes the very rapid appetitive learning of simple or complex stimuli (odorants or mixtures) through associative conditioning. We previously showed that 24h after MP-induced conditioning to odorants A (ethyl isobutyrate) or B (ethyl maltol), newborn rabbits perceive the AB mixture in a weak configural way, i.e. they perceive the odour of the AB configuration in addition to the odours of the elements. Moreover, after conditioning to the m…

animal nouveau néretention[ SDV.AEN ] Life Sciences [q-bio]/Food and NutritionCognitive Neurosciencemedia_common.quotation_subjectconfigural perception;memory persistence;newborn;odor mixture;retention;stimulus representation;oryctolagus cuniculusContext (language use)Competition (biology)odour mixturelcsh:RC321-571oryctolagus cuniculusPharmacological treatment03 medical and health sciencesBehavioral Neuroscience0302 clinical medicinemémoirenewbornFood and NutritionMemory persistenceRetention periodOriginal Research Articlelapinodor mixtureconfigural perceptionodeurlcsh:Neurosciences. Biological psychiatry. Neuropsychiatry030304 developmental biologymedia_commonmemory persistencestimulus representation0303 health sciencesCommunicationphéromone femellebusiness.industryNeurosciencesNeuropsychology and Physiological PsychologyOdor[ SDV.NEU ] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]Neurons and CognitionAlimentation et NutritionPheromoneConditioning[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]Psychologybusiness[SDV.AEN]Life Sciences [q-bio]/Food and NutritionNeuroscience030217 neurology & neurosurgeryNeuroscienceFrontiers in Behavioral Neuroscience
researchProduct

Pharmacological modulation of redox signaling pathways in disease

2020

chemistry.chemical_classificationReactive oxygen speciesbusiness.industryOxidation reductionDiseaseBiochemistrychemistryPhysiology (medical)MedicinePharmacological modulationSignal transductionbusinessOxidation-ReductionNeuroscienceSignal TransductionIntroductory Journal ArticleFree Radical Biology and Medicine
researchProduct

A Kinetic Model of Short- and Long-Term Potentiation

1993

We present a kinetic model that can account for several experimental findings on short- and long-term potentiation (STP and LTP) and their pharmacological modulation. The model, which is consistent with Hebb's postulate, uses the hypothesis that part of the origin of LTP may be a consequence of an increased release of neurotransmitter due to a retrograde signal. The operation of the model is expressed by a set of irreversible reactions, each of which should be thought of as equivalent to a set of more complex reactions. We show that a retrograde signal alone is not sufficient to maintain LTP unless long-term change of the rate constant of some of the reactions is caused by high-frequency s…

chemistry.chemical_compoundArts and Humanities (miscellaneous)chemistryKinetic modelMechanism (biology)Cognitive NeuroscienceStimulationLong-term potentiationPharmacological modulationNeurotransmitterSet (psychology)NeuroscienceNeural Computation
researchProduct

1,4 dihidropiridinski derivati povećavaju ekspresiju gena Psma3, Psmb5 i Psmc6 u glasničkoj RNA štakora

2021

The ubiquitin-proteasome system modifies different cellular and protein functions. Its dysregulation may lead to disrupted proteostasis associated with multiple pathologies and aging. Pharmacological regulation of proteasome functions is already an important part of the treatment of several diseases. 1,4-dihydropyridine (1,4-DHP) derivatives possess different pharmacological activities, including antiaging and neuroprotective. The aim of this study was to investigate the effects of several 1,4-DHP derivatives on mRNA expression levels of proteasomal genes Psma3, Psmb5, and Psmc6 in several organs of rats. Rats were treated with metcarbatone, etcarbatone, glutapyrone, styrylcarbatone, AV-153…

glutapironDihydropyridinesProteasome Endopeptidase Complexetcarbatoneporemećena proteasomska funkcijaimpaired proteasomal functionsproteasome subunitsToxicologyPSMA3metkarbatonKidneyNeuroprotectionPSMC6glutapyroneAV-153-NaAV-153-Ca; AV-153-Na; etcarbatone; gene expression; glutapyrone; impaired proteasomal functions; metcarbatone; pharmacological activities; proteasome subunits; styrylcarbatone; ubiquitin-proteasome systemAV-153-Ca; AV-153-Na; etkarbaton; glutapiron; metkarbaton; stirilkarbaton; poremećena proteasomska funkcija; proteasomske podjedinice; ubikvitin-proteasomski sustavGene expressionAnimalsstyrylcarbatoneRNA MessengerGeneChemistryPublic Health Environmental and Occupational HealthPSMB5Cell biologyproteasomske podjediniceRatsProteostasisProteasomeubikvitin-proteasomski sustavstirilkarbatongene expressionOriginal Articlepharmacological activitiesAV-153-Caubiquitin-proteasome systemmetcarbatoneetkarbatonArchives of Industrial Hygiene and Toxicology
researchProduct

Crystal structure of hydrocortisone 17-butyrate

2014

In the title compound, C25H36O6, the two central cyclohexane rings exhibit a chair conformation. The terminal cyclohexene and cyclopentane rings are in half-chair and envelope conformations (with the C atom bearing the methyl substituent as the flap), respectively. The methyl group of the butyrate chain is disordered over two orientations, with a refined occupancy ratio of 0.742 (6):0.258 (6). Intramolecular O—H...O and C—H...O hydrogen bonds are observed. In the crystal, molecules are linked by O—H...O hydrogen bonds into chains running parallel to theaaxis.

inorganic chemicalscrystal structureCrystallographyHydrogen bondCyclohexane conformationeducationGeneral ChemistryButyrateCrystal structureCondensed Matter PhysicsBioinformaticsData ReportshumanitiesCrystalchemistry.chemical_compoundCrystallographychemistryQD901-999Atomhydrogen bondshydro­cortisone derivativehydrocortisone derivativeGeneral Materials Sciencepharmacological activityMethyl groupActa Crystallographica Section E
researchProduct

Modulation of the Endocannabinoids N-Arachidonoylethanolamine (AEA) and 2-Arachidonoylglycerol (2-AG) on Executive Functions in Human.

2013

Animal studies point to an implication of the endocannabinoid system on executive functions. In humans, several studies have suggested an association between acute or chronic use of exogenous cannabinoids (Δ9-tetrahydrocannabinol) and executive impairments. However, to date, no published reports establish the relationship between endocannabinoids, as biomarkers of the cannabinoid neurotransmission system, and executive functioning in humans. The aim of the present study was to explore the association between circulating levels of plasma endocannabinoids N-arachidonoylethanolamine (AEA) and 2-Arachidonoylglycerol (2-AG) and executive functions (decision making, response inhibition and cognit…

lcsh:MedicineNeuropsychological TestsSocial and Behavioral SciencesPrefrontal cortexReceptores de cannabinoides:Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings]Executive FunctionEndocrinologyCognitionWisconsin Card Sorting TestEndocrinologiaHuman PerformanceMedicinePsychologyendocannabinoid systemPrefrontal cortexlcsh:ScienceProblem SolvingPsychiatryMultidisciplinaryCognitive NeurologyCognitive flexibilityPresa de decisionsCognitionMiddle AgedExecutive functionsexecutive functionsHumanos2-arachidonoylglycerolSubstance abuseEndocannabinoidesMental HealthNeurologyCognicióMedicineFemalelipids (amino acids peptides and proteins):Chemicals and Drugs::Amino Acids Peptides and Proteins::Proteins::Membrane Proteins::Receptors Cell Surface::Receptors G-Protein-Coupled::Receptors Cannabinoid [Medical Subject Headings]Animal behaviorClinical psychology:Chemicals and Drugs::Lipids::Fatty Acids::Fatty Acids Unsaturated::Arachidonic Acids [Medical Subject Headings]HumanResearch ArticleAdultN-arachidonoylethanolamine:Psychiatry and Psychology::Mental Disorders::Substance-Related Disorders::Marijuana Abuse [Medical Subject Headings]Polyunsaturated AlkamidesCognitive NeuroscienceDecision MakingArachidonic AcidsGlyceridesYoung AdultCannabinoides -- ReceptorsNeuropsychologyCànnabis:Diseases::Nervous System Diseases::Neurodegenerative Diseases [Medical Subject Headings]Pruebas neuropsicológicasÁcidos araquidónicosHumansFunción ejecutivaBiologyCannabisCannabinoides -- Efectes fisiològics:Anatomy::Nervous System::Central Nervous System [Medical Subject Headings]Behavior:Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Molecular Mechanisms of Pharmacological Action::Neurotransmitter Agents::Endocannabinoids [Medical Subject Headings]business.industrylcsh:RCognitive Psychologymedicine.diseaseIowa gambling taskEnfermedades neurodegenerativasAbuso de marihuanaSistema nervioso central:Psychiatry and Psychology::Behavioral Disciplines and Activities::Psychological Tests::Neuropsychological Tests [Medical Subject Headings]:Psychiatry and Psychology::Psychological Phenomena and Processes::Mental Processes::Executive Function [Medical Subject Headings]lcsh:QbusinessDecision makingStroop effectNeuroscienceEndocannabinoids
researchProduct

ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis.

2018

Background and purpose: Multiple sclerosis (MS) is a complex disease of the central nervous system. As new drugs are becoming available, knowledge on diagnosis and treatment must continuously evolve. There is therefore a need for a reference tool compiling current data on benefit and safety, to aid professionals in treatment decisions and use of resources across Europe. The European Committee of Treatment and Research in Multiple Sclerosis (ECTRIMS) and the European Academy of Neurology (EAN) have joined forces to meet this need. The objective was to develop an evidence-based clinical practice guideline for the pharmacological treatment of people with MS to guide healthcare professionals in…

medicine.medical_specialtyConsensusMultiple SclerosisdemyelinatingComplex diseasedisease-modifying therapies GRADE methodology guideline Multiple sclerosis Neurology Neurology (clinical)Outcome (game theory)Pharmacological treatmentImmunomodulation03 medical and health sciences0302 clinical medicineIntervention (counseling)GRADE methodologyAgency (sociology)Nominal group techniquemedicineImmunologic FactorsRelevance (law)Humans030212 general & internal medicineneurological disorderdisease-modifying therapiesIntensive care medicineSocieties MedicaldiseaseEvidence-Based Medicinebusiness.industryMultiple sclerosisdisease-modifying treatmentGuidelinemedicine.diseaseresearch methodEuropeNeurologymultiple sclerosiFamily medicinePractice Guidelines as TopicNeurology (clinical)businessguideline030217 neurology & neurosurgeryEuropean journal of neurology
researchProduct

Guidelines for the conduct of pharmacological clinical trials in hand osteoarthritis: Consensus of a Working Group of the European Society on Clinica…

2017

Objectives To gather expert opinion on the conduct of clinical trials that will facilitate regulatory review and approval of appropriate efficacious pharmacological treatments for hand osteoarthritis (OA), an area of high unmet clinical need. Methods The European Society on Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal diseases (ESCEO) organized a working group under the auspices of the International Osteoporosis Foundation (IOF) and the World Health Organization (WHO). Results This consensus guideline is intended to provide a reference tool for practice, and should allow for better standardization of the conduct of clinical trials in hand OA. Hand OA is …

medicine.medical_specialtyConsensusStandardizationHand JointsOsteoporosisOsteoarthritisDiseaseGuidelinesArticle03 medical and health sciences0302 clinical medicineClinical trialsRheumatologyOsteoarthritisHand osteoarthritismedicineHumans030212 general & internal medicineIntensive care medicineClinical trials; Guidelines; Hand osteoarthritis; Pharmacological treatment030203 arthritis & rheumatologyClinical Trials as Topicbusiness.industryclinical trialmedicine.diseaseClinical trialAnesthesiology and Pain MedicineResearch DesignExpert opinionAntirheumatic Agentshand osteoarthritibusinessguidelinePharmacological treatmentHand osteoarthritisConsensus guideline
researchProduct

Current Pharmacological Treatment of Painful Diabetic Neuropathy: A Narrative Review.

2020

Background and Objectives: Distal symmetrical polyneuropathy (DSPN) is one of the most common chronic complications of diabetes mellitus. Although it is usually characterized by progressive sensory loss, some patients may develop chronic pain. Assessment of DSPN is not difficult, but the biggest challenge is making the correct diagnosis and choosing the right treatment. The treatment of DSPN has three primary objectives: glycemic control, pathogenic mechanisms, and pain management. The aim of this brief narrative review is to summarize the current pharmacological treatment of painful DSPN. It also summarizes knowledge on pathogenesis-oriented therapy, which is generally overlooked in many p…

medicine.medical_specialtyDiabetic neuropathyAdministration TopicalMEDLINEPregabalinReviewCochrane LibraryDiabetic Neuropathiespharmacological treatmentDiabetes mellitusMedicineHumansPain ManagementpainIntensive care medicinelcsh:R5-920business.industryDiabetes mellitus Neuropathy Pain Pharmacological treatment Administration Topical Analgesics Opioid Anticonvulsants Antidepressive Agents Diabetic Neuropathies Humans Pain ManagementChronic painGeneral Medicinemedicine.diseaseAntidepressive AgentsAnalgesics OpioidNeuropathic paindiabetes mellitusAnticonvulsantsneuropathylcsh:Medicine (General)businessPolyneuropathymedicine.drugMedicina (Kaunas, Lithuania)
researchProduct